Time to second biochemical recurrence as a prognostic indicator in postprostatectomy patients who undergo salvage radiation therapy: An RTOG 9601 based post hoc analysis.

Autor: Brodowsky EC; Department of Urology, VCORE-Vattikuti Urology Institute Center for Outcomes Research, Analytics and Evaluation, Henry Ford Hospital, Detroit, Michigan, USA.; Department of Urology, Vattikuti Urology Institute, Henry Ford Hospital, Detroit, Michigan, USA., Sood A; Department of Urology, VCORE-Vattikuti Urology Institute Center for Outcomes Research, Analytics and Evaluation, Henry Ford Hospital, Detroit, Michigan, USA.; Department of Urology, Vattikuti Urology Institute, Henry Ford Hospital, Detroit, Michigan, USA.; Department of Urology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Butaney M; Department of Urology, VCORE-Vattikuti Urology Institute Center for Outcomes Research, Analytics and Evaluation, Henry Ford Hospital, Detroit, Michigan, USA., Majdalany SE; Department of Urology, VCORE-Vattikuti Urology Institute Center for Outcomes Research, Analytics and Evaluation, Henry Ford Hospital, Detroit, Michigan, USA., Stephens A; Department of Urology, VCORE-Vattikuti Urology Institute Center for Outcomes Research, Analytics and Evaluation, Henry Ford Hospital, Detroit, Michigan, USA., Corsi N; Division of Medicine, School of Medicine, Wayne State University, Detroit, Michigan, USA., Piontkowski AJ; Division of Medicine, School of Medicine, Wayne State University, Detroit, Michigan, USA., Rakic I; Division of Medicine, School of Medicine, Wayne State University, Detroit, Michigan, USA., Jamil M; Department of Urology, VCORE-Vattikuti Urology Institute Center for Outcomes Research, Analytics and Evaluation, Henry Ford Hospital, Detroit, Michigan, USA.; Department of Urology, Vattikuti Urology Institute, Henry Ford Hospital, Detroit, Michigan, USA., Dalela D; Department of Urology, VCORE-Vattikuti Urology Institute Center for Outcomes Research, Analytics and Evaluation, Henry Ford Hospital, Detroit, Michigan, USA.; Department of Urology, Vattikuti Urology Institute, Henry Ford Hospital, Detroit, Michigan, USA., Peabody JO; Department of Urology, VCORE-Vattikuti Urology Institute Center for Outcomes Research, Analytics and Evaluation, Henry Ford Hospital, Detroit, Michigan, USA.; Department of Urology, Vattikuti Urology Institute, Henry Ford Hospital, Detroit, Michigan, USA., Rogers CG; Department of Urology, VCORE-Vattikuti Urology Institute Center for Outcomes Research, Analytics and Evaluation, Henry Ford Hospital, Detroit, Michigan, USA.; Department of Urology, Vattikuti Urology Institute, Henry Ford Hospital, Detroit, Michigan, USA., Abdollah F; Department of Urology, VCORE-Vattikuti Urology Institute Center for Outcomes Research, Analytics and Evaluation, Henry Ford Hospital, Detroit, Michigan, USA.; Department of Urology, Vattikuti Urology Institute, Henry Ford Hospital, Detroit, Michigan, USA.

Publikováno v: The Prostate [Prostate] 2023 Jan; Vol. 83 (1), pp. 64-70. Date of Electronic Publication: 2022 Sep 19.